Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 13;9(1):131-134.
doi: 10.1080/23320885.2022.2071275. eCollection 2022.

Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?

Matthew J Davies  1 , Darrell Perkins  2
Affiliations
Case Reports

Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?

Matthew J Davies et al. Case Reports Plast Surg Hand Surg. .

Abstract

Two cases are presented that demonstrate normal wound healing following bilateral reduction mammoplasty, in young female patients taking therapeutic doses of Isotretinoin (Roaccutane). Review of the literature does not provide evidence that Isotretinoin impairs would healing, nor that it promotes hypertrophic or keloid scarring in surgical patients.

Keywords: Isotretinoin; healing; hypertrophic; scar; surgery.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Patient 1, 9 months post bilateral reduction mammoplasty.
Figure 2.
Figure 2.
Patient 2, 16 months post bilateral reduction mammoplasty.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Abergel RP, Meeker CA, Oikarinen H, et al. . Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. Arch Dermatol. 1985;121(5):632–635. - PubMed
    1. Wootton C, Cartwright R, Manning P, et al. . Should isotretinoin be stopped prior to surgery? A critically appraised topic. Br J Dermatol. 2014;170(2):239–244. - PubMed
    1. Spring LK, Krakowski AC, Alam M, et al. . Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations. JAMA Dermatol. 2017;153(8):802–809. - PubMed
    1. Bruno N, Beacham B, Burnett J.. Adverse effects of isotretinoin therapy. Cutis. 1984;33(5):484–486. - PubMed
    1. Hernandez‐Perez E, Khawaja HA, Alvarez TYM.. Oral isotretinoin as part of the treatment of cutaneous aging. Dermatol Surg. 2000;26(7):649–652. - PubMed

Publication types

LinkOut - more resources